Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 5
1981 5
1982 6
1983 9
1984 12
1985 16
1986 15
1987 27
1988 36
1989 19
1990 34
1991 37
1992 49
1993 56
1994 55
1995 64
1996 60
1997 62
1998 84
1999 88
2000 100
2001 131
2002 157
2003 188
2004 290
2005 391
2006 447
2007 519
2008 578
2009 700
2010 869
2011 1060
2012 1275
2013 1555
2014 1902
2015 2201
2016 2355
2017 2519
2018 2807
2019 3305
2020 4134
2021 4723
2022 5597
2023 5510
2024 2120

Text availability

Article attribute

Article type

Publication date

Search Results

41,177 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Zhang Q, Gao Y, Wang T, Bo Z, Ji B. Zhang Q, et al. Among authors: gao y. Transfusion. 2024 Mar;64(3):561-563. doi: 10.1111/trf.17733. Transfusion. 2024. PMID: 38488297 No abstract available.
Research beneficiaries speak.
Ye Q, Gao Y, Patel RJ, Cao B, Li A, Powell J, Cai Y, Marín-Beltrán I, Tao Z, Ejaz M, Zaidi SS, Gupta A, See MS, Cao XE, Fulco G, Lei C, Han S, Teng D, Bezerra P, Xia Y, Montesdeoca Molina BR, Zhang T, Heim AB, Uzonyi A. Ye Q, et al. Among authors: gao y. Science. 2024 Apr 5;384(6691):26-28. doi: 10.1126/science.adp2180. Epub 2024 Apr 4. Science. 2024. PMID: 38574143 No abstract available.
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC, Chang TC, Wang Y, Guo L, Gao Y, Bikorimana E, Lemoff A, Fang YV, Zhang H, Zhang Y, Ye D, Soria-Bretones I, Servetto A, Lee KM, Luo X, Otto JJ, Akamatsu H, Napolitano F, Mani R, Cescon DW, Xu L, Xie Y, Mendell JT, Hanker AB, Arteaga CL. Lin CC, et al. Among authors: gao y. Nat Commun. 2024 Mar 13;15(1):2287. doi: 10.1038/s41467-024-46495-2. Nat Commun. 2024. PMID: 38480701 Free PMC article.
Transport mechanism and pharmacology of the human GlyT1.
Wei Y, Li R, Meng Y, Hu T, Zhao J, Gao Y, Bai Q, Li N, Zhao Y. Wei Y, et al. Among authors: gao y. Cell. 2024 Mar 28;187(7):1719-1732.e14. doi: 10.1016/j.cell.2024.02.026. Epub 2024 Mar 20. Cell. 2024. PMID: 38513663
Immune checkpoint inhibitors and acute kidney injury.
Zhou P, Gao Y, Kong Z, Wang J, Si S, Han W, Li J, Lv Z, Wang R. Zhou P, et al. Among authors: gao y. Front Immunol. 2024 Feb 23;15:1353339. doi: 10.3389/fimmu.2024.1353339. eCollection 2024. Front Immunol. 2024. PMID: 38464524 Free PMC article. Review.
Time-resolved cryo-EM of G-protein activation by a GPCR.
Papasergi-Scott MM, Pérez-Hernández G, Batebi H, Gao Y, Eskici G, Seven AB, Panova O, Hilger D, Casiraghi M, He F, Maul L, Gmeiner P, Kobilka BK, Hildebrand PW, Skiniotis G. Papasergi-Scott MM, et al. Among authors: gao y. Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07153-1. Online ahead of print. Nature. 2024. PMID: 38480881
41,177 results
You have reached the last available page of results. Please see the User Guide for more information.